Dr. Frank van Leth
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study